Timothy Grange, MD
Physical Medicine & Rehabilitation · Salt Lake City, UTNPI 1932169430
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,053 of the $11,315 with a category attached, or 80.0%. It is spread thinly across 57 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among physical medicine & rehabilitation clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 490 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Biohaven Pharmaceuticals, Inc.$1K
- Boston Scientific$998
- Medtronic$983
- Collegium Pharmaceutical, Inc.$848
- Pfizer$624
- plus $5K from 51 others
What the payments were for
- Consulting fees$1,20011%
- Travel & lodging$1,0349%
- Food & beverage$9,05380%
- Education$290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,200
- ADAPTIVESTIM$530
- INTELLIS ADAPTIVESTIM$268
- RESTORE$127
- Ozempic$122
- SPRINT PNS System$120
- VERQUVO$117
- UBRELVY$114
- VRAYLAR$113
- SUBLOCADE$112
- AIMOVIG$105
How this compares
$11,315 in reported general payments places this provider in the 95th percentile of 117 physical medicine & rehabilitation providers in Utah.
See all physical medicine & rehabilitation providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 27 | $41,221 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 217 | $33,916 |
| Nucynta ErTapentadol Hcl | 20 | $25,611 |
| Xtampza ErOxycodone Myristate | 39 | $22,210 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 552 | $20,598 |
| Buprenorphine | 56 | $17,994 |
| Buprenorphine Hcl | 509 | $15,784 |
| UbrelvyUbrogepant | 14 | $14,527 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 511 | $12,240 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $10,251 |
| OzempicSemaglutide | 11 | $10,025 |
| Gabapentin | 456 | $9,116 |
| Morphine Sulfate ErMorphine Sulfate | 237 | $8,259 |
| Fentanyl | 44 | $5,966 |
| Oxycodone Hcl | 277 | $5,021 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Buprenorphine, Buprenorphine Hcl, Morphine Sulfate | $21 | $69,864829 claims |
| Collegium Pharmaceutical, Inc.Nucynta Er, Xtampza Er | $848 | $47,82259 claims |
| AbbVieUbrelvy | $1,797 | $14,52714 claims |
| Indivior Inc.Suboxone | $569 | $10,25115 claims |
| Novo NordiskOzempic | $122 | $10,02511 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $230 | $1,23329 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 117 physical medicine & rehabilitation providers in Utah.
Other physical medicine & rehabilitation in Salt Lake City
- Steven EdgleySalt Lake City$8K
- Taylor BurnhamSalt Lake City$7K
- Nicholas GavernSalt Lake City$5K
- Marc CarageaSalt Lake City$5K
- Arlan HenrieSalt Lake City$4K
- Max EpsteinSalt Lake City$4K
- Aaron CongerSalt Lake City$2K
- Gabriel Martinez AlvarezSalt Lake City$2K
- Jeffrey RosenbluthSalt Lake City$1K
- Derek KreteSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.